{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:35:08Z","timestamp":1773113708851,"version":"3.50.1"},"reference-count":223,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.prp.2021.153528","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T22:43:22Z","timestamp":1623969802000},"page":"153528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Joint application of biochemical markers and imaging techniques in the accurate and early detection of glioblastoma"],"prefix":"10.1016","volume":"224","author":[{"given":"Seyed Hamed","family":"Jafari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-1262","authenticated-orcid":false,"given":"Nikta","family":"Rabiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Taghizadieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayad Mohammad Ali","family":"Mirazimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Kowsari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Farzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Razaghi Bahabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Hossein","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Alirezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Dashti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Nejati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.prp.2021.153528_bib2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s12031-020-01639-z","article-title":"Combination therapy with nanomicellar-curcumin and temozolomide for in vitro therapy of glioblastoma multiforme via wnt signaling pathways","volume":"70","author":"Bagherian","year":"2020","journal-title":"J. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12964-020-00623-9","article-title":"Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis","volume":"18","author":"Ghaemmaghami","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/jnc.14616","article-title":"Genetic and epigenetic contribution to astrocytic gliomas pathogenesis","volume":"148","author":"Khani","year":"2019","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/jcb.26300","article-title":"MiR-21: a key player in glioblastoma pathogenesis","volume":"119","author":"Masoudi","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"suppl_5","key":"10.1016\/j.prp.2021.153528_bib6","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014","volume":"19","author":"Ostrom","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib9","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1371\/journal.pone.0007752","article-title":"Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations","volume":"4","author":"Brennan","year":"2009","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41416-019-0603-6","article-title":"Circulating biomarkers in patients with glioblastoma","volume":"122","author":"M\u00fcller Bark","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/cgt.2016.48","article-title":"Glioblastoma: exosome and microRNA as novel diagnosis biomarkers","volume":"23","author":"Saadatpour","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.prp.2021.153528_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112040","article-title":"Therapeutic potentials of curcumin in the treatment of glioblstoma","volume":"188","author":"Shabaninejad","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.prp.2021.153528_bib15","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1470-2045(14)70314-6","article-title":"Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial","volume":"15","author":"Taal","year":"2014","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib16","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","article-title":"Glioblastoma: pathology, molecular mechanisms and markers","volume":"129","author":"Aldape","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2532090007","article-title":"Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"253","author":"Barajas RF","year":"2009","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.12112120","article-title":"Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas","volume":"264","author":"Baek","year":"2012","journal-title":"Radiology"},{"issue":"32","key":"10.1016\/j.prp.2021.153528_bib19","doi-asserted-by":"crossref","first-page":"33946","DOI":"10.1074\/jbc.M404298200","article-title":"Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity","volume":"279","author":"Xu","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.prp.2021.153528_bib20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/djq187","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism","volume":"102","author":"Reitman","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"issue":"7274","key":"10.1016\/j.prp.2021.153528_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.prp.2021.153528_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1470-2045(10)70053-X","article-title":"Isocitrate dehydrogenase-1 mutations: a fundamentally new understanding of diffuse glioma?","volume":"12","author":"Kloosterhof","year":"2011","journal-title":"Lancet Oncol."},{"issue":"5924","key":"10.1016\/j.prp.2021.153528_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrc2818","article-title":"Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma","volume":"10","author":"Huse","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib27","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1101\/gr.132738.111","article-title":"A heterozygous IDH1R132H\/WT mutation induces genome-wide alterations in DNA methylation","volume":"22","author":"Duncan","year":"2012","journal-title":"Genome Res."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"issue":"7390","key":"10.1016\/j.prp.2021.153528_bib29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature10866","article-title":"IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype","volume":"483","author":"Turcan","year":"2012","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.prp.2021.153528_bib30","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000170088","article-title":"Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study","volume":"32","author":"Zawlik","year":"2009","journal-title":"Neuroepidemiology"},{"issue":"19","key":"10.1016\/j.prp.2021.153528_bib32","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2021.153528_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jnci\/djv041","article-title":"EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide","volume":"107","author":"Cominelli","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib34","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1084\/jem.183.6.2533","article-title":"CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells","volume":"183","author":"Krummel","year":"1996","journal-title":"J. Exp. Med."},{"issue":"14","key":"10.1016\/j.prp.2021.153528_bib35","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1158\/1078-0432.CCR-10-2232","article-title":"Cytotoxic T-lymphocyte-associated antigen-4","volume":"17","author":"Salama","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib36","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","article-title":"Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages","volume":"19","author":"Bloch","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm1517","article-title":"Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma","volume":"13","author":"Parsa","year":"2007","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1158\/2326-6066.CIR-13-0028","article-title":"Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas","volume":"1","author":"Doucette","year":"2013","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"10.1016\/j.prp.2021.153528_bib39","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/neuonc\/nou307","article-title":"Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma","volume":"17","author":"Berghoff","year":"2015","journal-title":"Neuro Oncol."},{"issue":"35","key":"10.1016\/j.prp.2021.153528_bib40","doi-asserted-by":"crossref","first-page":"14231","DOI":"10.1523\/JNEUROSCI.5812-12.2013","article-title":"PD-L1 expression by neurons nearby tumors indicates better prognosis in glioblastoma patients","volume":"33","author":"Liu","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prp.2021.153528_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.omtn.2021.03.011","article-title":"Cell death pathways and viruses: role of microRNAs. Molecular therapy","volume":"24","author":"Sadri Nahand","year":"2021","journal-title":"Nucleic Acids"},{"key":"10.1016\/j.prp.2021.153528_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107641","article-title":"Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC","volume":"97","author":"Donyavi","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12964-020-00668-w","article-title":"Effects of therapeutic probiotics on modulation of microRNAs","volume":"19","author":"Davoodvandi","year":"2021","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.prp.2021.153528_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105199","article-title":"Sensing the scent of death: Modulation of microRNAs by Curcumin in gastrointestinal cancers","volume":"160","author":"Ashrafizadeh","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.prp.2021.153528_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105133","article-title":"Autophagy-related microRNAs: possible regulatory roles and therapeutic potential in and gastrointestinal cancers","volume":"161","author":"Pourhanifeh","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.prp.2021.153528_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103063","article-title":"Autophagy-related microRNAs in chronic lung diseases and lung cancer","volume":"153","author":"Rezaei","year":"2020","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.prp.2021.153528_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104355","article-title":"The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV\/HCV, HIV\/HBV Co-infection and elite controllers for determination of biomarker","volume":"147","author":"Yousefpouran","year":"2020","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12964-020-00587-w","article-title":"Autophagy in cancers including brain tumors: role of MicroRNAs","volume":"18","author":"Pourhanifeh","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"9","key":"10.1016\/j.prp.2021.153528_bib49","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/iub.2325","article-title":"Role of microRNAs in Staphylococcus aureus infection: Potential biomarkers and mechanism","volume":"72","author":"Mirzaei","year":"2020","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib50","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/jcp.25799","article-title":"State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia","volume":"233","author":"Mirzaei","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib51","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/jcp.25801","article-title":"MicroRNAs: potential candidates for diagnosis and treatment of colorectal cancer","volume":"233","author":"Moridikia","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib52","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/jcp.25738","article-title":"Anti-atherosclerotic effects of vitamins D and E in suppression of atherogenesis","volume":"232","author":"Rashidi","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.prp.2021.153528_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/cgt.2016.34","article-title":"Circulating microRNA-192 as a diagnostic biomarker in human chronic lymphocytic leukemia","volume":"23","author":"Fathullahzadeh","year":"2016","journal-title":"Cancer Gene Ther."},{"issue":"9","key":"10.1016\/j.prp.2021.153528_bib54","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/1568009616666151207110143","article-title":"Epi-drugs and epi-miRs: moving beyond current cancer therapies","volume":"16","author":"Salarinia","year":"2016","journal-title":"Curr. Cancer Drug Targets"},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/cgt.2016.45","article-title":"Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma","volume":"23","author":"Mohammadi","year":"2016","journal-title":"Cancer Gene Ther."},{"issue":"36","key":"10.1016\/j.prp.2021.153528_bib56","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.2174\/0929867323666160818093854","article-title":"Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in gastric cancer: current status and future perspectives","volume":"23","author":"Mirzaei","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib57","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/1381612822666151112151924","article-title":"The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment","volume":"22","author":"Gholamin","year":"2016","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.prp.2021.153528_bib58","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/iub.2277","article-title":"Autophagy regulation by microRNAs: novel insights into osteosarcoma therapy","volume":"72","author":"Jamali","year":"2020","journal-title":"IUBMB Life"},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/iub.2222","article-title":"The role of miR-146a in viral infection","volume":"72","author":"Nahand","year":"2020","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib60","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/0929867326666191212102407","article-title":"Role of resveratrol in modulating microRNAs in human diseases: from cancer to inflammatory disorder","volume":"28","author":"Amiri","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib61","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/hiv.12822","article-title":"MicroRNAs and exosomes: key players in HIV pathogenesis","volume":"21","author":"Sadri Nahand","year":"2020","journal-title":"HIV Med."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib62","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1615\/CritRevEukaryotGeneExpr.2019025273","article-title":"MicroRNAs as diagnostic, prognostic, and therapeutic biomarkers in prostate cancer","volume":"29","author":"Aghdam","year":"2019","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib63","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/1566524019666191001113511","article-title":"The role of microRNAs in lung cancer: implications for diagnosis and therapy","volume":"20","author":"Naeli","year":"2020","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.prp.2021.153528_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2019.113349","article-title":"Electrochemical-based biosensors for microRNA detection: nanotechnology comes into view","volume":"581","author":"Shabaninejad","year":"2019","journal-title":"Anal. Biochem."},{"issue":"10","key":"10.1016\/j.prp.2021.153528_bib65","doi-asserted-by":"crossref","first-page":"17064","DOI":"10.1002\/jcp.28457","article-title":"microRNAs: new prognostic, diagnostic, and therapeutic biomarkers in cervical cancer","volume":"234","author":"Nahand","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib66","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1002\/jcp.27755","article-title":"Molecular aspects of pancreatic \u03b2-cell dysfunction: oxidative stress, microRNA, and long noncoding RNA","volume":"234","author":"Saeedi Borujeni","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib67","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1002\/jcb.26012","article-title":"MicroRNAs-based imaging techniques in cancer diagnosis and therapy","volume":"118","author":"Keshavarzi","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib68","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcp.25793","article-title":"GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma","volume":"233","author":"Gholamin","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib69","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/jcp.25787","article-title":"MicroRNA: relevance to stroke diagnosis, prognosis, and therapy","volume":"233","author":"Mirzaei","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib70","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1159\/000485279","article-title":"Bufalin inhibits cellular proliferation and cancer stem cell-like phenotypes via upregulation of MiR-203 in glioma","volume":"44","author":"Liu","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib71","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-017-0685-9","article-title":"Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p","volume":"16","author":"Lu","year":"2017","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib72","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.1002\/jcb.27108","article-title":"MicroRNA-150-5p affects cell proliferation, apoptosis, and EMT by regulation of the BRAFV600E mutation in papillary thyroid cancer cells","volume":"119","author":"Yan","year":"2018","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.prp.2021.153528_bib73","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fphar.2016.00439","article-title":"miR-150 suppresses the proliferation and tumorigenicity of leukemia stem cells by targeting the nanog signaling pathway","volume":"7","author":"Xu","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.prp.2021.153528_bib74","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.4049\/jimmunol.1800304","article-title":"Therapeutic potential of mesenchymal cell-derived miRNA-150-5p-expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF","volume":"201","author":"Chen","year":"2018","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gene.2016.04.058","article-title":"miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase","volume":"587","author":"Sakr","year":"2016","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib77","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jcp.27186","article-title":"Wnt\/\u03b2-catenin signaling cascade: a promising target for glioma therapy","volume":"234","author":"He","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.prp.2021.153528_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181346","article-title":"Wnt\/\u03b2-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms","volume":"12","author":"Gao","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib79","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1159\/000491888","article-title":"MiR-4319 suppress the malignancy of triple-negative breast cancer by regulating self-renewal and tumorigenesis of stem cells","volume":"48","author":"Chu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib80","first-page":"1162","article-title":"MicroRNA-200a suppresses the Wnt\/\u03b2-catenin signaling pathway by interacting with \u03b2-catenin","volume":"40","author":"Su","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib81","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/cbin.11314","article-title":"miR-150-5p suppresses the stem cell-like characteristics of glioma cells by targeting the Wnt\/\u03b2-catenin signaling pathway","volume":"44","author":"Tian","year":"2020","journal-title":"Cell Biol. Int."},{"issue":"15","key":"10.1016\/j.prp.2021.153528_bib82","doi-asserted-by":"crossref","first-page":"19960","DOI":"10.18632\/oncotarget.6963","article-title":"Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma","volume":"7","author":"Zang","year":"2016","journal-title":"Oncotarget"},{"issue":"33","key":"10.1016\/j.prp.2021.153528_bib83","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.2174\/1381612825666190830161528","article-title":"Long non-coding RNAs as epigenetic regulators in cancer","volume":"25","author":"Vafadar","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.prp.2021.153528_bib84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.omtn.2020.05.012","article-title":"Non-coding RNAs and exosomes: their role in the pathogenesis of sepsis","volume":"21","author":"Hashemian","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib85","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2174\/0929867327666200204141952","article-title":"Exosomes and lung cancer: roles in pathophysiology, diagnosis and therapeutic applications","volume":"28","author":"Amiri","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.prp.2021.153528_bib86","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.omto.2021.04.002","article-title":"Angiogenesis-related non-coding RNAs and gastrointestinal cancer","volume":"21","author":"Razavi","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.prp.2021.153528_bib87","article-title":"Pivotal role of TGF-\u03b2\/Smad signaling in cardiac fibrosis: non-coding RNAs as effectual players","volume":"7","author":"Saadat","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.prp.2021.153528_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103192","article-title":"Gynecologic cancers and non-coding RNAs: epigenetic regulators with emerging roles","volume":"157","author":"Razavi","year":"2021","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"10.1016\/j.prp.2021.153528_bib89","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.omto.2020.10.003","article-title":"Regulation of glycolysis by non-coding RNAs in cancer: switching on the Warburg effect","volume":"19","author":"Mirzaei","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.prp.2021.153528_bib90","article-title":"New epigenetic players in stroke pathogenesis: from non-coding RNAs to exosomal non-coding RNAs","volume":"140","author":"Mahjoubin-Tehran","year":"2021","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib91","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ygyno.2021.03.020","article-title":"Non-coding RNAs related to angiogenesis in gynecological cancer","volume":"161","author":"Rahimian","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib92","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ygyno.2021.02.004","article-title":"Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers","volume":"161","author":"Hashemipour","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2021.153528_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41417-020-00272-7","article-title":"Autophagy and gastrointestinal cancers: the behind the scenes role of long non-coding RNAs in initiation, progression, and treatment resistance","author":"Shafabakhsh","year":"2021","journal-title":"Cancer Gene Ther."},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib94","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00432-016-2332-z","article-title":"Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme","volume":"143","author":"Wang","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"39","key":"10.1016\/j.prp.2021.153528_bib95","doi-asserted-by":"crossref","first-page":"63901","DOI":"10.18632\/oncotarget.11564","article-title":"Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22","volume":"7","author":"Luan","year":"2016","journal-title":"Oncotarget"},{"issue":"27","key":"10.1016\/j.prp.2021.153528_bib96","doi-asserted-by":"crossref","first-page":"43768","DOI":"10.18632\/oncotarget.10844","article-title":"LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib97","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/jcb.26021","article-title":"The long non-coding RNA TP73-AS1 interacted with miR-142 to modulate brain glioma growth through HMGB1\/RAGE pathway","volume":"119","author":"Zhang","year":"2018","journal-title":"J. Cell Biochem."},{"issue":"13","key":"10.1016\/j.prp.2021.153528_bib98","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2217\/bmm-2020-0167","article-title":"Circular RNA as a potential diagnostic and\/or therapeutic target for endometriosis","volume":"14","author":"Dana","year":"2020","journal-title":"Biomark. Med."},{"key":"10.1016\/j.prp.2021.153528_bib99","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fmicb.2020.01853","article-title":"Circular RNAs: new epigenetic signatures in viral infections","volume":"11","author":"Nahand","year":"2020","journal-title":"Front. Microbiol."},{"issue":"7","key":"10.1016\/j.prp.2021.153528_bib100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2217\/bmm-2019-0567","article-title":"Circular RNAs: new genetic tools in melanoma","volume":"14","author":"Hallajzadeh","year":"2020","journal-title":"Biomark. Med."},{"issue":"7","key":"10.1016\/j.prp.2021.153528_bib101","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2174\/1566524020666200129142106","article-title":"Circular RNA and diabetes: epigenetic regulator with diagnostic role","volume":"20","author":"Abbaszadeh-Goudarzi","year":"2020","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.prp.2021.153528_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102854","article-title":"Circular RNAs and gastrointestinal cancers: epigenetic regulators with a prognostic and therapeutic role","volume":"145","author":"Naeli","year":"2020","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13048-019-0558-5","article-title":"Circular RNAs in cancer: new insights into functions and implications in ovarian cancer","volume":"12","author":"Shabaninejad","year":"2019","journal-title":"J. Ovarian Res."},{"issue":"10","key":"10.1016\/j.prp.2021.153528_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153217","article-title":"Circular RNAs: new players in thyroid cancer","volume":"216","author":"Borran","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"17","key":"10.1016\/j.prp.2021.153528_bib105","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1158\/0008-5472.CAN-18-0532","article-title":"CircNT5E acts as a sponge of miR-422a to promote glioblastoma tumorigenesis","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib106","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1261\/rna.035667.112","article-title":"Circular RNAs are abundant, conserved, and associated with ALU repeats","volume":"19","author":"Jeck","year":"2013","journal-title":"RNA"},{"issue":"7","key":"10.1016\/j.prp.2021.153528_bib107","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1093\/nar\/gkr1009","article-title":"Transcriptome-wide discovery of circular RNAs in Archaea","volume":"40","author":"Danan","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib108","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.prp.2021.153528_bib109","doi-asserted-by":"crossref","first-page":"7112","DOI":"10.1073\/pnas.1305322110","article-title":"Deciphering the rules of ceRNA networks","volume":"110","author":"Cesana","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7301","key":"10.1016\/j.prp.2021.153528_bib110","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nature09144","article-title":"A coding-independent function of gene and pseudogene mRNAs regulates tumour biology","volume":"465","author":"Poliseno","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib111","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cell.2011.09.028","article-title":"A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA","volume":"147","author":"Cesana","year":"2011","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib112","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1261\/rna.2414110","article-title":"MicroRNA sponges: progress and possibilities","volume":"16","author":"Ebert","year":"2010","journal-title":"RNA"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib113","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cell.2011.09.032","article-title":"In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma","volume":"147","author":"Karreth","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib114","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2011.09.029","article-title":"Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs","volume":"147","author":"Tay","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cell.2011.09.041","article-title":"An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma","volume":"147","author":"Sumazin","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib116","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12943-018-0911-0","article-title":"EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"issue":"18","key":"10.1016\/j.prp.2021.153528_bib117","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2217\/epi-2020-0026","article-title":"Exosomal microRNAs: novel players in cervical cancer","volume":"12","author":"Nahand","year":"2020","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib118","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12964-020-00650-6","article-title":"Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages","volume":"18","author":"Asgarpour","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib119","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/iub.2211","article-title":"MicroRNAs and exosomes: small molecules with big actions in multiple myeloma pathogenesis","volume":"72","author":"Pourhanifeh","year":"2020","journal-title":"IUBMB Life"},{"issue":"14","key":"10.1016\/j.prp.2021.153528_bib120","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.2217\/epi-2019-0110","article-title":"miRNAs derived from cancer-associated fibroblasts in colorectal cancer","volume":"11","author":"Savardashtaki","year":"2019","journal-title":"Epigenomics"},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib121","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/iub.2182","article-title":"Exosomes and cancer: from oncogenic roles to therapeutic applications","volume":"72","author":"Mohammadi","year":"2020","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib122","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ijc.32688","article-title":"Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: a review","volume":"146","author":"Sadri Nahand","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib123","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/jcp.25739","article-title":"and therapeutic potential of exosomes in cancer: the beginning of a new tale?","volume":"232","author":"Mirzaei","year":"2017","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib124","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib125","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/0008-5472.CAN-13-2650","article-title":"Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1","volume":"74","author":"Bronisz","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib126","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/neuonc\/nov244","article-title":"Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia\/macrophages in the brain","volume":"18","author":"van der Vos","year":"2016","journal-title":"Neuro Oncol."},{"issue":"7","key":"10.1016\/j.prp.2021.153528_bib127","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.cell.2012.11.024","article-title":"Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration","volume":"151","author":"Luga","year":"2012","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib128","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/bjc.2014.14","article-title":"Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer","volume":"110","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.prp.2021.153528_bib129","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1158\/0008-5472.CAN-16-2524","article-title":"Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of miR-1587","volume":"77","author":"Figueroa","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cytogfr.2006.09.010","article-title":"The regulation and role of osteopontin in malignant transformation and cancer","volume":"17","author":"El-Tanani","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7050","key":"10.1016\/j.prp.2021.153528_bib131","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature03799","article-title":"Genes that mediate breast cancer metastasis to lung","volume":"436","author":"Minn","year":"2005","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.prp.2021.153528_bib132","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib133","first-page":"3417","article-title":"Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer","volume":"62","author":"Rudland","year":"2002","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.prp.2021.153528_bib134","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1038\/sj.onc.1209305","article-title":"Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization","volume":"25","author":"Colin","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2567.2010.03335.x","article-title":"Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma","volume":"132","author":"Atai","year":"2011","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib136","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/jcb.21520","article-title":"Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management","volume":"102","author":"Tuck","year":"2007","journal-title":"J. Cell Biochem."},{"issue":"7","key":"10.1016\/j.prp.2021.153528_bib137","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1021\/pr200210w","article-title":"Secretome signature of invasive glioblastoma multiforme","volume":"10","author":"Formolo","year":"2011","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib138","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/neuonc\/nop013","article-title":"Osteopontin regulates human glioma cell invasiveness and tumor growth in mice","volume":"12","author":"Jan","year":"2010","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.prp.2021.153528_bib139","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/ijc.24751","article-title":"Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model","volume":"126","author":"Lamour","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"49","key":"10.1016\/j.prp.2021.153528_bib140","doi-asserted-by":"crossref","first-page":"46024","DOI":"10.1074\/jbc.M105132200","article-title":"The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase\/Akt signaling pathway","volume":"276","author":"Lin","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prp.2021.153528_bib141","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.pharmtox.41.1.723","article-title":"Role of osteopontin in cellular signaling and toxicant injury","volume":"41","author":"Denhardt","year":"2001","journal-title":"Annu Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib142","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jss.2004.03.028","article-title":"The role of Osteopontin in tumor metastasis","volume":"121","author":"Wai","year":"2004","journal-title":"J. Surg. Res."},{"issue":"26","key":"10.1016\/j.prp.2021.153528_bib143","doi-asserted-by":"crossref","first-page":"17789","DOI":"10.1074\/jbc.M708629200","article-title":"Thrombin hydrolysis of human osteopontin is dependent on thrombin anion-binding exosites","volume":"283","author":"Myles","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib144","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/excr.1998.4108","article-title":"Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin","volume":"242","author":"Smith","year":"1998","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib145","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1083\/jcb.145.2.413","article-title":"The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1","volume":"145","author":"Taooka","year":"1999","journal-title":"J. Cell Biol."},{"issue":"51","key":"10.1016\/j.prp.2021.153528_bib146","doi-asserted-by":"crossref","first-page":"36328","DOI":"10.1074\/jbc.274.51.36328","article-title":"The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin","volume":"274","author":"Yokosaki","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib147","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1006\/bbrc.1999.2032","article-title":"A regulated interaction between alpha5beta1 integrin and osteopontin","volume":"267","author":"Barry","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib148","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/excr.2000.4941","article-title":"Analysis of the alpha4beta1 integrin-osteopontin interaction","volume":"258","author":"Barry","year":"2000","journal-title":"Exp. Cell Res."},{"issue":"16","key":"10.1016\/j.prp.2021.153528_bib149","doi-asserted-by":"crossref","first-page":"13483","DOI":"10.1074\/jbc.M011392200","article-title":"Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin","volume":"276","author":"Bayless","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(01)02690-4","article-title":"Structural elements of the osteopontin SVVYGLR motif important for the interaction with alpha(4) integrins","volume":"503","author":"Green","year":"2001","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib151","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1074\/jbc.M112.362954","article-title":"Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage","volume":"288","author":"Yamaguchi","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib152","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1179\/016164107X235149","article-title":"Decreased levels of interleukin-10 and transforming growth factor-beta 2 in cerebrospinal fluid of patients with high grade astrocytoma","volume":"30","author":"Krzyszkowski","year":"2008","journal-title":"Neurol. Res."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib153","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","article-title":"Genetic pathways to primary and secondary glioblastoma","volume":"170","author":"Ohgaki","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib154","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1750-3639.2009.00270.x","article-title":"Galectins and gliomas","volume":"20","author":"Le Mercier","year":"2010","journal-title":"Brain Pathol."},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib155","doi-asserted-by":"crossref","first-page":"137r","DOI":"10.1093\/glycob\/cwl025","article-title":"Galectin-1: a small protein with major functions","volume":"16","author":"Camby","year":"2006","journal-title":"Glycobiology"},{"issue":"15","key":"10.1016\/j.prp.2021.153528_bib156","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1182\/blood-2011-12-396457","article-title":"Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma","volume":"119","author":"Cedeno-Laurent","year":"2012","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.prp.2021.153528_bib157","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1158\/1078-0432.CCR-11-1462","article-title":"Serum galectin-2, -4, and -8 are greatly increased in colon and breast cancer patients and promote cancer cell adhesion to blood vascular endothelium","volume":"17","author":"Barrow","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib158","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3174\/ajnr.A2397","article-title":"Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma","volume":"32","author":"Hygino da Cruz","year":"2011","journal-title":"Am. J. Neuroradiol."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib159","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/NEN.0b013e318170f892","article-title":"Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses","volume":"67","author":"Le Mercier","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"17","key":"10.1016\/j.prp.2021.153528_bib160","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood-2012-12-474569","article-title":"Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma","volume":"121","author":"Ouyang","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib161","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"20","key":"10.1016\/j.prp.2021.153528_bib162","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/sim.1228","article-title":"Estimation of the area under the ROC curve","volume":"21","author":"Faraggi","year":"2002","journal-title":"Stat. Med."},{"issue":"7","key":"10.1016\/j.prp.2021.153528_bib163","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jnen\/61.7.585","article-title":"Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases","volume":"61","author":"Camby","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib164","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1535-6108(04)00024-8","article-title":"Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege","volume":"5","author":"Rubinstein","year":"2004","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib165","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2217\/fon.10.71","article-title":"Salirasib in the treatment of pancreatic cancer","volume":"6","author":"Bustinza-Linares","year":"2010","journal-title":"Fut. Oncol."},{"issue":"29","key":"10.1016\/j.prp.2021.153528_bib166","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.2174\/092986706779026219","article-title":"Anti-galectin compounds as potential anti-cancer drugs","volume":"13","author":"Ingrassia","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib167","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-013-1201-8","article-title":"Altered galectin-1 serum levels in patients diagnosed with high-grade glioma","volume":"115","author":"Verschuere","year":"2013","journal-title":"J. Neuro-Oncol."},{"issue":"7","key":"10.1016\/j.prp.2021.153528_bib168","first-page":"562","article-title":"Diagnostic accuracy of perfusion computed tomography in cerebral glioma grading","volume":"26","author":"Ahmad","year":"2016","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib169","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1148\/radiology.150.2.6691098","article-title":"Primary intracranial tumor imaging: a comparison of magnetic resonance and CT","volume":"150","author":"Brant-Zawadzki","year":"1984","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib170","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1148\/radiology.169.3.3187000","article-title":"Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors","volume":"169","author":"Just","year":"1988","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib171","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00598951","article-title":"Magnetic resonance imaging and histopathology of cerebral gliomas","volume":"34","author":"Watanabe","year":"1992","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib172","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1148\/radiology.211.3.r99jn46791","article-title":"Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging","volume":"211","author":"Knopp","year":"1999","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib173","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3171\/jns.1993.79.4.0533","article-title":"Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma","volume":"79","author":"Kondziolka","year":"1993","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib174","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1148\/radiology.174.2.2153310","article-title":"Gliomas: classification with MR imaging","volume":"174","author":"Dean","year":"1990","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib175","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0090-3019(97)00360-1","article-title":"The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series","volume":"49","author":"Ginsberg","year":"1998","journal-title":"Surg. Neurol."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib176","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/1097-0142(19850901)56:5<1106::AID-CNCR2820560525>3.0.CO;2-2","article-title":"Glioblastoma multiforme and anaplastic astrocytoma pathologic criteria and prognostic implications","volume":"56","author":"Burger","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2021.153528_bib177","unstructured":"P.C. Burger, editor Malignant astrocytic neoplasms: classification, pathologic anatomy, and response to treatment. Seminars in oncology, 1986."},{"key":"10.1016\/j.prp.2021.153528_bib178","series-title":"Seminars in Radiation Oncology","article-title":"Advances in magnetic resonance imaging and positron emission tomography imaging for grading and molecular characterization of glioma","author":"Chung","year":"2015"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib179","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clineuro.2012.11.002","article-title":"Potential of MR spectroscopy for assessment of glioma grading","volume":"115","author":"Bulik","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib180","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.ejrad.2014.09.018","article-title":"Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis","volume":"83","author":"Zhang","year":"2014","journal-title":"Eur. J. Radiol."},{"issue":"9","key":"10.1016\/j.prp.2021.153528_bib181","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1474-4422(10)70181-2","article-title":"Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas","volume":"9","author":"Dhermain","year":"2010","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib182","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib183","first-page":"1559","article-title":"Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma","volume":"18","author":"Nagashima","year":"2016","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib184","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3171\/2016.10.JNS161793","article-title":"Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting","volume":"128","author":"Tietze","year":"2017","journal-title":"J. Neurosurg."},{"issue":"31","key":"10.1016\/j.prp.2021.153528_bib185","doi-asserted-by":"crossref","first-page":"32257","DOI":"10.18632\/oncotarget.4899","article-title":"Dynamic 1H-MRS assessment of brain tumors: a novel approach for differential diagnosis of glioma","volume":"6","author":"Tong","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.prp.2021.153528_bib186","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1007\/s00330-015-4046-z","article-title":"The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: a systematic review and meta-analysis","volume":"26","author":"Wang","year":"2016","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib187","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1148\/radiol.2513080899","article-title":"Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one-versus two-parameter pilot method","volume":"251","author":"Murakami","year":"2009","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib188","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00004728-200411000-00003","article-title":"The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors","volume":"28","author":"Bulakbasi","year":"2004","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib189","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1148\/radiol.2322030959","article-title":"Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging","volume":"232","author":"Provenzale","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.prp.2021.153528_bib190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5812\/iranjradiol.13696","article-title":"Diagnostic efficacy of perfusion magnetic resonance imaging in supratentorial glioma grading","volume":"15","author":"Ghodsi","year":"2018","journal-title":"Iran. J. Radiol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43055-019-0127-3","article-title":"Perfusion and permeability MRI in glioma grading","volume":"51","author":"Aydin","year":"2020","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"key":"10.1016\/j.prp.2021.153528_bib192","doi-asserted-by":"crossref","first-page":"14397","DOI":"10.1097\/MD.0000000000014397","article-title":"Comparison of dual-time point 18F-FDG PET\/CT tumor-to-background ratio, intraoperative 5-aminolevulinic acid fluorescence scale, and Ki-67 index in high-grade glioma","volume":"98","author":"Y-i","year":"2019","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib193","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejrnm.2015.04.011","article-title":"The diagnostic value of dual phase FDG PET CT in grading of gliomas","volume":"46","author":"Ghany","year":"2015","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib194","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11307-009-0215-2","article-title":"NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3\u2019-deoxy-3\u2019-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies","volume":"11","author":"Spence","year":"2009","journal-title":"Mol. Imaging Biol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiology.195.1.7892494","article-title":"Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET","volume":"195","author":"Delbeke","year":"1995","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib196","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/RLU.0b013e3181db4cfb","article-title":"The efficacy of dual time point F-18 FDG PET imaging for grading of brain tumors","volume":"35","author":"Kim","year":"2010","journal-title":"Clin. Nucl. Med."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib197","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ejrad.2010.07.017","article-title":"Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas","volume":"80","author":"Server","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.prp.2021.153528_bib198","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejmp.2019.03.014","article-title":"Imaging biomarker analysis of advanced multiparametric MRI for glioma grading","volume":"60","author":"Vamvakas","year":"2019","journal-title":"Phys. Med."},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib199","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejrnm.2016.07.006","article-title":"Preoperative glioma grading by MR diffusion and MR spectroscopic imaging","volume":"47","author":"Fawzy","year":"2016","journal-title":"Egypt. J. Radiol. Nucl. Med."},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib200","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3174\/ajnr.A2846","article-title":"The added value of apparent diffusion coefficient to cerebral blood volume in the preoperative grading of diffuse gliomas","volume":"33","author":"Hilario","year":"2012","journal-title":"Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib201","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-009-9807-6","article-title":"Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging","volume":"94","author":"Arvinda","year":"2009","journal-title":"J. Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.prp.2021.153528_bib202","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s11060-009-9880-x","article-title":"Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status","volume":"92","author":"Kapoor","year":"2009","journal-title":"J. Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib203","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520914466","article-title":"Radiomic prediction models for the level of Ki-67 and p53 in glioma","volume":"48","author":"Sun","year":"2020","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib204","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11060-015-1829-7","article-title":"Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival","volume":"124","author":"Kiviniemi","year":"2015","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib205","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00330-017-4964-z","article-title":"MRI features can predict EGFR expression in lower grade gliomas: a voxel-based radiomic analysis","volume":"28","author":"Li","year":"2018","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib206","first-page":"1826","article-title":"MMP-2 expression and correlation with pathology and MRI of glioma","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib207","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1674-8301(10)60020-6","article-title":"The relationship between the expression of tumor matrix-metalloproteinase and the characteristics of magnetic resonance imaging of human gliomas","volume":"24","author":"Liu","year":"2010","journal-title":"J. Biomed. Res."},{"issue":"6","key":"10.1016\/j.prp.2021.153528_bib208","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3892\/ol.2011.384","article-title":"Expression of VEGF and MMP-9 and MRI imaging changes in cerebral glioma","volume":"2","author":"Liu","year":"2011","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.prp.2021.153528_bib209","first-page":"5607","article-title":"The combined use of EphA2\/MMP\u20112 expression and MRI findings contributes to the determination of cerebral glioma grade","volume":"18","author":"Suo","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.prp.2021.153528_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108714","article-title":"Fusion Radiomics Features From Conventional MRI predict MGMT promoter methylation status in lower grade gliomas","volume":"121","author":"Jiang","year":"2019","journal-title":"Eur. J. Radiol."},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib211","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.3174\/ajnr.A3604","article-title":"Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma","volume":"34","author":"Young","year":"2013","journal-title":"Am. J. Neuroradiol."},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib212","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3174\/ajnr.A4484","article-title":"T1-weighted dynamic contrast-enhanced MRI as a noninvasive biomarker of epidermal growth factor receptor vIII status","volume":"36","author":"Arevalo-Perez","year":"2015","journal-title":"Am. J. Neuroradiol."},{"issue":"1","key":"10.1016\/j.prp.2021.153528_bib213","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11060-017-2506-9","article-title":"Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II\u2013III diffuse gliomas","volume":"134","author":"Leu","year":"2017","journal-title":"J. Neuro-Oncol."},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib214","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nm.2682","article-title":"2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas","volume":"18","author":"Choi","year":"2012","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib215","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3171\/2016.10.JNS161793","article-title":"Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting","volume":"128","author":"Tietze","year":"2018","journal-title":"J. Neurosurg."},{"issue":"11","key":"10.1016\/j.prp.2021.153528_bib216","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/neuonc\/nor117","article-title":"Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas","volume":"13","author":"Iwamoto","year":"2011","journal-title":"Neuro-Oncology"},{"issue":"12","key":"10.1016\/j.prp.2021.153528_bib217","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/neuonc\/noy073","article-title":"Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T","volume":"20","author":"Paech","year":"2018","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib218","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11060-008-9611-8","article-title":"99m Tc-Tetrofosmin brain SPECT in the assessment of meningiomas\u2014correlation with histological grade and proliferation index","volume":"89","author":"Fotopoulos","year":"2008","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.prp.2021.153528_bib219","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11060-005-9074-0","article-title":"Tc-99m Tetrofosmin SPECT for the differentiation of a cerebellar hemorrhage mimicking a brain metastasis from a renal cell carcinoma","volume":"78","author":"Alexiou","year":"2006","journal-title":"J. Neuro-Oncol."},{"issue":"4","key":"10.1016\/j.prp.2021.153528_bib220","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11307-009-0202-7","article-title":"99m Tc-Tetrofosmin SPECT for glioma evaluation","volume":"11","author":"Alexiou","year":"2009","journal-title":"Mol. Imaging Biol."},{"issue":"supplement 2","key":"10.1016\/j.prp.2021.153528_bib221","article-title":"Detection of tumor recurrence by 99mTc-Tetrofosmin brain SPECT in the follow-up of irradiated gliomas","volume":"48","author":"Alexiou","year":"2007","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.prp.2021.153528_bib222","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.wneu.2016.01.085","article-title":"Prognostic value of O-(2-[18F]-fluoroethyl)-L-tyrosine-positron emission tomography imaging for histopathologic characteristics and progression-free survival in patients with low-grade glioma","volume":"89","author":"Bette","year":"2016","journal-title":"World Neurosurg."},{"issue":"8","key":"10.1016\/j.prp.2021.153528_bib223","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00259-017-3677-5","article-title":"[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesis","volume":"44","author":"Bekaert","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821001898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821001898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:48:32Z","timestamp":1759733312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033821001898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":223,"alternative-id":["S0344033821001898"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153528","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Joint application of biochemical markers and imaging techniques in the accurate and early detection of glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153528"}}